Search Results - "Zinkstok, J R"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith–Magenis syndrome: protocol for a series of N-of-1 trials by Müller, A. R, Zinkstok, J. R, Rommelse, N. N. J, van de Ven, P. M, Roes, K. C. B, Wijburg, F. A, de Rooij-Askes, E, Linders, C, Boot, E, van Eeghen, A. M

    Published in Orphanet journal of rare diseases (08-09-2021)
    “…Abstract Background Smith–Magenis syndrome (SMS) is a rare genetic neurodevelopmental disorder characterized by intellectual disability and severe behavioural…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Polygenic risk scores for genetic counseling in psychiatry: Lessons learned from other fields of medicine by Eeltink, E., van der Horst, M.Z., Zinkstok, J.R., Aalfs, C.M., Luykx, J.J.

    Published in Neuroscience and biobehavioral reviews (01-02-2021)
    “…•Polygenic risk score (PRS) prediction accuracy in psychiatry is low.•Integrating PRS with environmental factors will improve clinical applicability.•Setting…”
    Get full text
    Journal Article
  4. 4

    Striatal D2receptor binding in 22q11 deletion syndrome: an [123 I]IBZM SPECT study by Boot, E., Booij, J., Zinkstok, JR, de Haan, L., Linszen, DH, Baas, F., van Amelsvoort, TA

    Published in Journal of psychopharmacology (Oxford) (01-10-2010)
    “…It has been hypothesised that in subjects with 22q11 deletion syndrome (22q11DS) disturbances of the dopamine (DA) system contribute to their increased risk…”
    Get full text
    Journal Article
  5. 5

    Efficacy and tolerability of riluzole in psychiatric disorders: A systematic review and preliminary meta-analysis by de Boer, J.N., Vingerhoets, C., Hirdes, M., McAlonan, G.M., Amelsvoort, T.V., Zinkstok, J.R.

    Published in Psychiatry research (01-08-2019)
    “…•Twenty-three randomized-controlled trials were included for qualitative analysis.•Positive effects of riluzole were found in several psychiatric…”
    Get full text
    Journal Article
  6. 6

    White-matter relaxation time and myelin water fraction differences in young adults with autism by Deoni, S C L, Zinkstok, J R, Daly, E, Ecker, C, Williams, S C R, Murphy, D G M

    Published in Psychological medicine (01-03-2015)
    “…Increasing evidence suggests that autism is associated with abnormal white-matter (WM) anatomy and impaired brain 'connectivity'. While myelin plays a critical…”
    Get more information
    Journal Article
  7. 7

    Striatal D2 receptor binding in 22q11 deletion syndrome: an [123I]IBZM SPECT study by BOOT, E, BOOIJ, J, ZINKSTOK, J. R, DE HAAN, L, LINSZEN, D. H, BAAS, F, VAN AMELSVOORT, T. A

    Published in Journal of psychopharmacology (Oxford) (01-10-2010)
    “…It has been hypothesised that in subjects with 22q11 deletion syndrome (22q11DS) disturbances of the dopamine (DA) system contribute to their increased risk…”
    Get full text
    Journal Article
  8. 8

    Striatal D 2 receptor binding in 22q11 deletion syndrome: an [ 123 I]IBZM SPECT study by Boot, E., Booij, J., Zinkstok, JR, de Haan, L., Linszen, DH, Baas, F., van Amelsvoort, TA

    Published in Journal of psychopharmacology (Oxford) (01-10-2010)
    “…It has been hypothesised that in subjects with 22q11 deletion syndrome (22q11DS) disturbances of the dopamine (DA) system contribute to their increased risk…”
    Get full text
    Journal Article
  9. 9

    Practical guidelines for prescribing psychotropic medication to people with intellectual disability by de Kuijper, G, Degraeve, G, Zinkstok, J R

    Published in Tijdschrift voor psychiatrie (2019)
    “…In people with intellectual disability (id) prescription of psychotropic drugs is often chronic and outside licensed indications. AIM: To provide practical…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Striatal D^sub 2^receptor binding in 22q11 deletion syndrome: an [^sup 123^ I]IBZM SPECT study by Boot, E, Booij, J, Zinkstok, JR, de Haan, L, Linszen, DH, Baas, F, van Amelsvoort, TA

    Published in Journal of psychopharmacology (Oxford) (01-10-2010)
    “…It has been hypothesised that in subjects with 22q11 deletion syndrome (22q11DS) disturbances of the dopamine (DA) system contribute to their increased risk…”
    Get full text
    Journal Article